| 2022-10-19 |
复牌提示：
2022-10-18 19:50:02 停牌，复牌日期 2022-10-20 00:00:01
|
| 2022-09-14 |
股东大会：
将于2022-10-17召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal to adopt the Agreement and Plan of Merger, dated July 24, 2022 (the “Merger Agreement”), by and among Zymergen, Ginkgo Bioworks Holdings, Inc., a Delaware corporation (“Ginkgo”), and Pepper Merger Subsidiary Inc. a Delaware corporation and an indirect wholly owned subsidiary of Ginkgo (“Merger Sub”), as such agreement may be amended from time to time (the “Merger Proposal”). A copy of the Merger Agreement is attached as Annex A to the proxy statement/prospectus accompanying this notice;
2.To consider and vote on a proposal to approve adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies if sufficient votes to approve the Merger Proposal have not been obtained by Zymergen (the “Adjournment Proposal”).
|
| 2022-09-14 |
详情>>
股本变动：
变动后总股本10435.53万股
|
| 2022-08-15 |
详情>>
业绩披露：
2022年中报每股收益-1.83美元,归母净利润-1.89亿美元,同比去年增长-1.71%
|
| 2022-05-12 |
详情>>
业绩披露：
2022年一季报每股收益-0.7美元,归母净利润-7211.6万美元,同比去年增长14.74%
|
| 2022-05-12 |
财报披露：
美东时间 2022-05-12 盘后发布财报
|
| 2022-04-20 |
股东大会：
将于2022-06-02召开股东大会
会议内容 ▼▲
- 1.To elect the three nominees for director named herein to serve as Class I directors to hold office until the 2025 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified.
2.To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022.
3.To conduct any other business properly brought before the meeting or any adjournment or postponement thereof.
|
| 2022-03-30 |
详情>>
业绩披露：
2021年年报每股收益-4.87美元,归母净利润-3.62亿美元,同比去年增长-37.98%
|
| 2021-11-15 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-4.39美元,归母净利润-2.84亿美元,同比去年增长-52.01%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-16 |
详情>>
业绩披露：
2021年中报每股收益-4.07美元,归母净利润-1.85亿美元,同比去年增长-48.6%
|
| 2021-05-27 |
详情>>
业绩披露：
2021年一季报每股收益-6.51美元,归母净利润-8458.5万美元,同比去年增长-29.45%
|
| 2021-04-23 |
详情>>
业绩披露：
2020年年报每股收益-21.46美元,归母净利润-2.62亿美元,同比去年增长-10.72%
|
| 2021-03-05 |
详情>>
内部人交易：
Serber Zachariah股份减少67050.00股
|